A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB)

PHASE3CompletedINTERVENTIONAL
Enrollment

398

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Chronic Bronchitis
Interventions
OTHER

Moxifloxacin Placebo

1 capsule once daily for 5 days

DRUG

Moxifloxacin

1 X 400mg capsule once daily for 5 days

OTHER

Azithromycin SR Placebo

single dose, oral.

DRUG

Azithromycin SR

single dose 2.0 g oral

Trial Locations (34)

100

Pfizer Investigational Site, Taipei

114

Pfizer Investigational Site, Neihu

333

Pfizer Investigational Site, Kuei Shan Hsiang

404

Pfizer Investigational Site, Taichung

1000

Pfizer Investigational Site, Manila

1008

Pfizer Investigational Site, Manila

1100

Pfizer Investigational Site, Quezon City

1104

Pfizer Investigational Site, Quezon City

10110

Pfizer Investigational Site, Bangkok

10330

Pfizer Investigational Site, Vachira Dusit

10700

Pfizer Investigational Site, Bangkok

40002

Pfizer Investigational Site, Khon Kaen

40705

Pfizer Investigational Site, Taichung

50180

Pfizer Investigational Site, Maerim

50200

Pfizer Investigational Site, Chiang Mai

50603

Pfizer Investigational Site, Lembah Pantai

56000

Pfizer Investigational Site, Cheras

100034

Pfizer Investigational Site, Beijing

100083

Pfizer Investigational Site, Beijing

110016

Pfizer Investigational Site, Shenyang

169608

Pfizer Investigational Site, Singapore

200025

Pfizer Investigational Site, Shanghai

200040

Pfizer Investigational Site, Shanghai

200080

Pfizer Investigational Site, Shanghai

210002

Pfizer Investigational Site, Nanjing

308433

Pfizer Investigational Site, Singapore

310003

Pfizer Investigational Site, Hangzhou

310009

Pfizer Investigational Site, Hangzhou

400016

Pfizer Investigational Site, Chongqing

400037

Pfizer Investigational Site, Chongqing

510080

Pfizer Investigational Site, Guangzhou

710032

Pfizer Investigational Site, Xi’an

710061

Pfizer Investigational Site, Xi’an

050000

Pfizer Investigational Site, Shijiazhuang

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY